XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2014 45,537            
Balance at Dec. 31, 2014 $ 46 $ 742,006 $ 41,539 $ (8,668) $ 774,923 $ 11,823 $ 786,746
Stock-based compensation 3,077 3,077 3,077
Exercise of options by employees and directors (in shares) 502            
Exercise of options by employees and directors 4,612 4,612 4,612
Share exchange with Parent (in shares) 2,996            
Share exchange with Parent $ 3 26,012 26,015 26,015
Cash paid to non controlling interest (4,507) (4,507)
Cash dividend declared (9,772) (9,772) (9,772)
Issuance of shares to noncontrolling interest, net of transaction costs 71,291 71,291 85,470 156,761
Net income 96,585 96,585 2,616 99,201
Loss in respect of derivative instruments designated for cash flow hedge       68 68   68
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment       (4,154) (4,154)   (4,154)
Amortization of unrealized gains in respect of derivative instruments designated for cash flow hedge (90) (90) (90)
Balance (in shares) at Sep. 30, 2015 49,035            
Balance at Sep. 30, 2015 $ 49 846,998 128,352 (12,844) 962,555 95,402 1,057,957
Balance (in shares) at Dec. 31, 2015 49,107            
Balance at Dec. 31, 2015 $ 49 849,223 148,396 (7,667) 990,001 93,873 1,083,874
Stock-based compensation 3,383 3,383 3,383
Exercise of options by employees and directors (in shares) 528            
Exercise of options by employees and directors $ 1 7,249 7,250 7,250
Cash paid to non controlling interest (10,622) (10,622)
Cash dividend declared (22,469) (22,469) (22,469)
Issuance of shares to noncontrolling interest, net of transaction costs 8,272 8,272
Net income 65,700 65,700 4,390 70,284
Loss in respect of derivative instruments designated for cash flow hedge 65 65 65
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment (3,829) (3,829) (3,829)
Amortization of unrealized gains in respect of derivative instruments designated for cash flow hedge (72) (72) (72)
Balance (in shares) at Sep. 30, 2016 49,635            
Balance at Sep. 30, 2016 $ 50 $ 859,855 $ 191,627 $ (11,503) $ 1,040,029 $ 95,913 $ 1,135,942